OOIR: Observatory of International Research

Papers

(The TQCC of Diabetes & Vascular Disease Research is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Early detection of diabetic nephropathy in patient with type 2 diabetes mellitus: A review of the literature	93
Safety of four SGLT2 inhibitors in three chronic diseases: A meta-analysis of large randomized trials of SGLT2 inhibitors	52
Baicalin ameliorates atherosclerosis by inhibiting NLRP3 inflammasome in apolipoprotein E-deficient mice	32
Epigallocatechin-3-gallate ameliorates glucolipid metabolism and oxidative stress in type 2 diabetic rats	28
The impact of flash glucose monitoring on glycated hemoglobin in type 2 diabetes managed with basal insulin in Canada: A retrospective real-world chart review study	27
The association between sodium-glucose cotransporter 2 inhibitors and incident dementia: A nationwide population-based longitudinal cohort study	25
Comparative study of microvascular structural changes in the gestational diabetic placenta	20
Triglyceride-glucose index is prospectively associated with chronic kidney disease progression in Type 2 diabetes – mediation by pigment epithelium-derived factor	15
Diabetes, metformin and glucose lowering therapies after myocardial infarction: Insights from the SWEDEHEART registry	15
Low levels of circulating anti-ageing hormone Klotho predict the onset and progression of diabetic retinopathy	13
Sleep behaviours and associated habits and the progression of pre-diabetes to type 2 diabetes mellitus in adults: A systematic review and meta-analysis	11
Impaired subendocardial perfusion in patients with metabolic syndrome	11
Plasma advanced glycation end products and soluble receptor for advanced glycation end products as indicators of sterol content in human carotid atherosclerotic plaques	11
Cardiovascular outcomes and LDL-cholesterol levels in EMPA-REG OUTCOME^®	9
Impact of COVID-19 therapy on hyperglycemia	9
Vascular inflammation, atherosclerosis, and lipid metabolism and the occurrence of non-high albuminuria diabetic kidney disease: A cross-sectional study	9
Glucose variability is associated with an adverse vascular profile but only in the presence of insulin resistance in individuals with type 1 diabetes: An observational study	9
Plasma levels of tissue inhibitor of metalloproteinase-1 in patients with type 1 diabetes mellitus associate with early diabetic neuropathy and nephropathy	8
Impact of insulin therapy on outcomes of diabetic patients with heart failure: A systematic review and meta-analysis	8
Use of continuous glucose monitoring trend arrows in the younger population with type 1 diabetes	8
Extracellular vesicles in gestational diabetes mellitus: A scoping review	8
Shared and specific biological signalling pathways for diabetic retinopathy, peripheral neuropathy and nephropathy by high-throughput sequencing analysis	8
Deteriorated regional calf microcirculation measured by contrast-free MRI in patients with diabetes mellitus and relation with physical activity	8
Hyperinsulinemia alters insulin receptor presentation and internalization in brain microvascular endothelial cells	8
Genetic variation in CARD8, a gene coding for an NLRP3 inflammasome-associated protein, alters the genetic risk for diabetic nephropathy in the context of type 2 diabetes mellitus	7

TyG-BMI and hypertension in Normoglycemia subjects in Japan: A cross-sectional study	7
Endothelial deletion of PKCδ prevents VEGF inhibition and restores blood flow reperfusion in diabetic ischemic limb	7
DNA aptamer raised against receptor for advanced glycation end products suppresses renal tubular damage and improves insulin resistance in diabetic mice	7
Restoration of coronary microvascular function by OGA overexpression in a high-fat diet with low-dose streptozotocin-induced type 2 diabetic mice	7
Plasma proteomics reveals an improved cardio-metabolic profile in patients with type 2 diabetes post-liraglutide treatment	7
Accurate prediction of HbA1c by continuous glucose monitoring using a kinetic model with patient-specific parameters for red blood cell lifespan and glucose uptake	7
Association of triglyceride-glucose with cardiac hemodynamics in type 2 diabetes	7
Real life evaluation of sodium-glucose cotransporter 2 inhibition in type 1 diabetes and the risk of diabetic ketoacidosis	7
Silencing of FOS-like antigen 1 represses restenosis via the ERK/AP-1 pathway in type 2 diabetic mice	7